Evidence map›Paper›PMID 30197980›Full record

ArticleKidney international reports2018

Prevalence and Risk Factors for CKD: A Comparison Between the Adult Populations in China and the United States.

Fang Wang, Kevin He, Jinwei Wang, Ming-Hui Zhao, Yi Li, Luxia Zhang, Rajiv Saran, Jennifer L Bragg-Gresham

Registry-linked trialOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07689578 (Safety and Efficacy of the Bispecific T-Cell Engager), which is not on this map. Cited by 49 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 2 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07689578 phase4recruitingnot on this mapstarted 2026, after this paper: background citation

Safety and Efficacy of the Bispecific T-Cell Engager (BiTE) in Kidney Transplant Recipients With Chronic Active Antibody-Mediated Rejection

TypeinterventionalSponsorTurun SongRan2026 to 2029Enrolled50ConditionsAntibody Mediated Rejection After Kidney TransplantationArmsBiTE (BCMA x CD3 Bispecific Antibody)
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 2 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Future perspective on chronic kidney disease management.Journal of anesthesia and translational medicine · 2025
    Review
  7. A qualitative study on the return to work experiences and views of young and middle-aged patient with chronic kidney disease.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Fang WangRenal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
Kevin HeDepartment of Biostatistics and the Kidney Epidemiology and Cost Center, University of Michigan, Ann Arbor, Michigan, USA.
Jinwei WangRenal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
Ming-Hui ZhaoRenal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
Yi LiDepartment of Biostatistics and the Kidney Epidemiology and Cost Center, University of Michigan, Ann Arbor, Michigan, USA.
Luxia ZhangRenal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
Rajiv SaranDivision of Nephrology, Department of Internal Medicine and the Kidney Epidemiology and Cost Center, University of Michigan, Ann Arbor, Michigan, USA.
Jennifer L Bragg-GreshamDivision of Nephrology, Department of Internal Medicine and the Kidney Epidemiology and Cost Center, University of Michigan, Ann Arbor, Michigan, USA.
University of Michigan–Ann Arbor · USPeking University · CNPeking University First Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionChronic kidney disease (CKD) is an important noncommunicable disease globally. Overall prevalence of CKD and distribution of its stages differ between countries. We postulate that these differences may not only be due to variation in prevalence of risk factors but also their differential impact in different populations or settings.

methodsWe used nationally representative data on the adult populations from both the United States (US; National Health and Nutrition Examination Survey [NHANES], 2009 to 2010, N = 5557) and China (China National Survey of CKD, 2009 to 2010, N = 46,949). Age, sex, central obesity, cardiovascular disease, diabetes, hypertension, and hyperuricemia were explored as candidate risk factors for CKD. The prevalence of CKD was calculated using survey weights.

resultsThe prevalence of decreased estimated glomerular filtration rate (eGFR), defined as eGFR < 60 ml/min per 1.73 m

conclusionPeople in China and the US share many common risk factors for CKD, but differences in prevalence and the potential impact of these risk factors for CKD were observed.

Indexed as

albuminuriachronic kidney diseasedecreased eGFRprevalence

Identifiers

PMID30197980
PMCPMC6127437
OpenAlexW2805907900

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.